Skip to content

REGNREGENERON PHARMACEUTICALS

CUSIP 75886F107 · common stock

12 tracked investors held REGENERON PHARMACEUTICALS (REGN) at the end of Q3 2026, worth $4B in total. The largest holder was Dodge & Cox, with 1.9% of its portfolio. 3 investors opened new positions this quarter, including Lee Ainslie.

Holders · Q3 2026
12
New holders
3
Value held
$4B
Quarter-end price (est.)
$758.27

Investors holding REGN · Q3 2026

InvestorWeightSharesValueChange
Dodge & Cox
Dodge & Cox
1.94%4,774,489$3.6BREDUCE-2.0%
Mason Hawkins
Southeastern Asset Management Inc
5.84%140,165$106.3MREDUCE-8.0%
Harry Burn
Sound Shore Management Inc
2.99%126,179$95.7MREDUCE-0.6%
Joel Greenblatt
Gotham Asset Management, LLC
0.13%87,040$66MREDUCE-17.2%
Jeremy Grantham
Grantham, Mayo, Van Otterloo & Co. LLC
0.12%71,076$53.9MREDUCE-4.2%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.53%16,446$12.5MREDUCE-25.9%
Lee Ainslie
Maverick Capital Ltd
0.01%1,824$1.4MNEW
Mario Gabelli
GAMCO Investors, Inc.
0.00%653$495.2KREDUCE-0.6%
Murray Stahl
Horizon Kinetics Asset Management LLC
0.01%585$443.6KREDUCE-9.3%
Mike Alfred
Alpine Fox Capital LLC
0.21%500$379.1KHOLD
Richard Pzena
Pzena Investment Management LLC
0.00%409$310.1KNEW
Ken Fisher
Fisher Asset Management, LLC
0.00%347$263.9KNEW

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 20261230$4B$758.27
Q2 2026901$3.3B$623.54
Q1 20261001$3.8B$772.64
Q4 20251100$3.9B$771.87